Oren Gilad

Chief Executive Officer at APREA THERAPEUTICS, INC.

Net worth: 2 M $ as of 2024-04-29

56 year

Health Technology

Consumer Services

Oren Gilad active positions

Companies	Position	Start	End
APREA THERAPEUTICS, INC.	Director/Board Member	2022-04-30	-
	Chief Executive Officer	2022-06-28	-
	President	2022-04-30	-

Companies	Position	Start	End
Atrin Pharmaceuticals LLC Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.	Director/Board Member	2010-12-31	2021-12-31
	Chief Executive Officer	2010-12-31	2021-12-31
	Founder	2010-12-31	2021-12-31
	President	2010-12-31	2021-12-31
Atrin Pharmaceuticals, Inc. Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.	Chief Executive Officer	2010-12-31	2021-12-31
	Founder	2010-12-31	2021-12-31
	President	2010-12-31	2021-12-31

The Hebrew University of Jerusalem	Undergraduate Degree
University of California, Davis	Doctorate Degree
University of Pennsylvania	Doctorate Degree

International

United States	6
Israel	2

Operational

Sectoral

Health Technology	4
Consumer Services	4

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
APREA THERAPEUTICS, INC.	Health Technology

Private companies	2
Atrin Pharmaceuticals LLC Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.	Health Technology
Atrin Pharmaceuticals, Inc. Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.	Health Technology

Private companies

Health Technology